Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2014-06-01 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PRAZ-SUR-ARLY (74120), Haute-Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU VAL D'ARLY : revenue, balance sheet and financial ratios
PHARMACIE DU VAL D'ARLY is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PRAZ-SUR-ARLY (74120),
this company of category PME
shows in 2023 a revenue of 1.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU VAL D'ARLY (SIREN 803412600)
Indicator
2024
2023
2017
Revenue
N/C
1 490 143 €
N/C
Net income
82 501 €
106 680 €
12 795 €
EBITDA
N/C
147 797 €
N/C
Net margin
N/C
7.2%
N/C
Revenue and income statement
In 2024, PHARMACIE DU VAL D'ARLY generates positive net income of 83 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 13 k€ -> 83 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
82 501 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 73%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
73.297%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
50.237%
Solvency indicators evolution PHARMACIE DU VAL D'ARLY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2023
2024
Debt ratio
1503.754
99.427
73.297
Financial autonomy
5.021
42.499
50.237
Repayment capacity
None
5.01
None
Cash flow / Revenue
None%
5.956%
None%
Sector positioning
Debt ratio
73.32024
2017
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average-21 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU VAL D'ARLY (73.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
50.24%2024
2017
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+26 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU VAL D'ARLY (50.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
5.01 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DU VAL D'ARLY (5.01) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU VAL D'ARLY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2023
2024
Operating WCR
0 €
-78 709 €
0 €
Inventory turnover (days)
0
0
0
Customer payment term (days)
0
0
0
Supplier payment term (days)
0
32
0
Positioning of PHARMACIE DU VAL D'ARLY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU VAL D'ARLY is estimated at
1 151 774 €
(range 802 077€ - 1 723 121€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
802k€1151k€1723k€
1 151 774 €Range: 802 077€ - 1 723 121€
NAF 5 année 2024
Valuation method used
Net Income Multiple
82 501 €
×
14.0x
=1 151 775 €
Range: 802 078€ - 1 723 121€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU VAL D'ARLY with other companies in the same sector:
Frequently asked questions about PHARMACIE DU VAL D'ARLY
What is the revenue of PHARMACIE DU VAL D'ARLY ?
The revenue of PHARMACIE DU VAL D'ARLY in 2023 is 1.5 M€.
Is PHARMACIE DU VAL D'ARLY profitable?
Yes, PHARMACIE DU VAL D'ARLY generated a net profit of 83 k€ in 2024.
Where is the headquarters of PHARMACIE DU VAL D'ARLY ?
The headquarters of PHARMACIE DU VAL D'ARLY is located in PRAZ-SUR-ARLY (74120), in the department Haute-Savoie.
Where to find the tax return of PHARMACIE DU VAL D'ARLY ?
The tax return of PHARMACIE DU VAL D'ARLY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU VAL D'ARLY operate?
PHARMACIE DU VAL D'ARLY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart